ZA983852B - Therapy for constipation - Google Patents

Therapy for constipation

Info

Publication number
ZA983852B
ZA983852B ZA983852A ZA983852A ZA983852B ZA 983852 B ZA983852 B ZA 983852B ZA 983852 A ZA983852 A ZA 983852A ZA 983852 A ZA983852 A ZA 983852A ZA 983852 B ZA983852 B ZA 983852B
Authority
ZA
South Africa
Prior art keywords
constipation
therapy
Prior art date
Application number
ZA983852A
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of ZA983852B publication Critical patent/ZA983852B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA983852A 1997-05-07 1998-05-07 Therapy for constipation ZA983852B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6653A AUPO665397A0 (en) 1997-05-07 1997-05-07 Novel therapy for constipation

Publications (1)

Publication Number Publication Date
ZA983852B true ZA983852B (en) 1998-11-13

Family

ID=3800945

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983852A ZA983852B (en) 1997-05-07 1998-05-07 Therapy for constipation

Country Status (13)

Country Link
US (1) US6426338B1 (da)
EP (1) EP0980246B1 (da)
AR (1) AR012671A1 (da)
AT (1) ATE349216T1 (da)
AU (1) AUPO665397A0 (da)
CA (1) CA2289717C (da)
CY (1) CY1107586T1 (da)
DE (1) DE69836735T2 (da)
DK (1) DK0980246T3 (da)
ES (1) ES2279573T3 (da)
PT (1) PT980246E (da)
WO (1) WO1998050043A1 (da)
ZA (1) ZA983852B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1313697T3 (da) 2000-08-29 2006-04-10 Nobex Corp Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
DE10257824B4 (de) * 2002-12-10 2004-11-11 Kochem, Hans-Günter, Dr. Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen
US20050075395A1 (en) * 2003-05-28 2005-04-07 Gary Gordon Continuous dosing regimen
CA2526385C (en) * 2003-05-29 2008-07-22 Abbott Laboratories Continuous dosing regimen with abt-751
US20040242649A1 (en) * 2003-05-29 2004-12-02 Hagey Anne E. Extended dosing regimen
JP2007520495A (ja) * 2004-02-06 2007-07-26 ボロディー トーマス ユリウス 下痢型過敏性腸症候群におけるアミノサリチル酸の使用法
US20050191371A1 (en) * 2004-02-12 2005-09-01 Rizo Andres M. Medical composition
US20080306029A1 (en) * 2004-05-28 2008-12-11 Salix Pharmaceuticals, Inc. Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
DK1773767T3 (da) 2004-07-07 2016-03-21 Biocon Ltd Syntese af azo-bundne immunregulerende forbindelser
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP2529729A1 (en) * 2005-08-24 2012-12-05 Salix Pharmaceuticals, Inc. Balsalazide formulations and manufacture thereof
US8772242B2 (en) 2009-10-26 2014-07-08 Thomas Julius Borody Therapy for enteric infections
DK3564357T3 (da) 2010-02-01 2022-06-20 Rebiotix Inc Bakterieterapi mod clostridium difficile colitis
JP2013525440A (ja) 2010-04-26 2013-06-20 サリックス ファーマシューティカルズ リミテッド 男性の治療のための2−ヒドロキシ−5−フェニルアゾ安息香酸誘導体の製剤および使用
AU2011342368B2 (en) 2010-12-13 2016-11-17 Rite-Prep Pty Ltd Gastric and colonic formulations and methods for making and using them
EP2830606A4 (en) * 2012-03-30 2015-08-12 Takeda Pharmaceuticals Usa Inc FORMULATIONS OF COLCHICINE; MANUFACTURING PROCESSES ; AND ASSOCIATED METHODS OF USE
PT2877163T (pt) 2012-07-27 2019-05-24 Redhill Biopharma Ltd Formulações e métodos de fabrico de formulações para utilização na evacuação colónica
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
KR102099503B1 (ko) 2013-06-05 2020-04-09 리바이오틱스, 인코퍼레이티드 미생물상 복원 요법(mrt) 조성물
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
ES2889902T3 (es) 2015-06-09 2022-01-14 Rebiotix Inc Métodos de fabricación de composiciones para terapia de restauración de la microbiota (TRM)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
CA2090220C (en) * 1990-10-22 2003-07-08 Thomas Julius Borody Treatment of non-inflammatory and non-infectious bowel disorders

Also Published As

Publication number Publication date
EP0980246A1 (en) 2000-02-23
DK0980246T3 (da) 2007-05-07
EP0980246A4 (en) 2004-04-14
AUPO665397A0 (en) 1997-05-29
US6426338B1 (en) 2002-07-30
AR012671A1 (es) 2000-11-08
ES2279573T3 (es) 2007-08-16
DE69836735T2 (de) 2007-10-11
ATE349216T1 (de) 2007-01-15
EP0980246B1 (en) 2006-12-27
WO1998050043A1 (en) 1998-11-12
CY1107586T1 (el) 2013-03-13
PT980246E (pt) 2007-02-28
CA2289717C (en) 2009-02-03
DE69836735D1 (de) 2007-02-08
CA2289717A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
ZA983852B (en) Therapy for constipation
EG24678A (en) Combination therapy
ZA983176B (en) Therapeutic compounds
GB9725782D0 (en) Therapeutic agents
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
IL127306A0 (en) Combination therapy
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
GB9700939D0 (en) Therapy
GB9702392D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9716345D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716463D0 (en) Therapeutic agents
GB9718254D0 (en) Therapeutic agents
GB9708698D0 (en) Materials for therapy
GB9716457D0 (en) Therapeutic agents
GB9704885D0 (en) Therapy
GB9705401D0 (en) Therapeutic compounds